176 related articles for article (PubMed ID: 27045744)
1. Potential role of the soluble form of CD40 in deficient immunological function of dialysis patients: new findings of its amelioration using polymethylmethacrylate (PMMA) membrane.
Contin-Bordes C; Lacraz A; de Précigout V
NDT Plus; 2010 May; 3(Suppl 1):i20-i27. PubMed ID: 27045744
[TBL] [Abstract][Full Text] [Related]
2. Enhancing Immune Protection in Hemodialysis Patients: Role of the Polymethyl Methacrylate Membrane.
Franzin R; Stasi A; Caggiano G; Squiccimarro E; Losappio V; Fiorentino M; Alfieri C; Stallone G; Gesualdo L; Castellano G
Blood Purif; 2023 Apr; 52(Suppl 1):1-13. PubMed ID: 37075738
[TBL] [Abstract][Full Text] [Related]
3. Polymethylmethacrylate strengthens antibody response in hemodialysis patients not responding to hepatitis B vaccine: preliminary data.
Duranti E; Duranti D
Minerva Med; 2011 Dec; 102(6):469-74. PubMed ID: 22193378
[TBL] [Abstract][Full Text] [Related]
4. Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients.
Contin C; Pitard V; Delmas Y; Pelletier N; Defrance T; Moreau JF; Merville P; Déchanet-Merville J
Immunology; 2003 Sep; 110(1):131-40. PubMed ID: 12941150
[TBL] [Abstract][Full Text] [Related]
5. Polymethylmethacrylate membrane with a series of serendipity.
Sakai Y
Contrib Nephrol; 2011; 173():137-147. PubMed ID: 21865786
[TBL] [Abstract][Full Text] [Related]
6. Trial use of a polymethylmethacrylate membrane for the removal of free immunoglobulin light chains in dialysis patients.
Oshihara W; Nagao H; Megano H; Arai J; Koide M; Takada M
NDT Plus; 2010 May; 3(Suppl 1):i3-i7. PubMed ID: 27046285
[No Abstract] [Full Text] [Related]
7. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
[TBL] [Abstract][Full Text] [Related]
8. Improved hepatitis B vaccination rates in ESRD patients in California.
Brown J; Peters V
Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S95-9. PubMed ID: 11053594
[TBL] [Abstract][Full Text] [Related]
9. Polymethylmethacrylate Membrane Dialyzer: Historic but Modern.
Torii Y; Yamada S; Yajima M; Sugata T
Blood Purif; 2022 Oct; 52(Suppl 1):1-7. PubMed ID: 36265445
[TBL] [Abstract][Full Text] [Related]
10. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L
Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845
[TBL] [Abstract][Full Text] [Related]
11. Long-term multicentre study on beta 2-microglobulin removal by PMMA BK membrane.
Arakawa M
Nephrol Dial Transplant; 1991; 6 Suppl 2():69-74. PubMed ID: 1866073
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell dysfunction in uremia: the role of oxidative stress and the effects of dialysis.
Peraldi MN; Berrou J; Métivier F; Toubert A
Blood Purif; 2013; 35 Suppl 2():14-9. PubMed ID: 23676830
[TBL] [Abstract][Full Text] [Related]
13. Beneficiary characteristics and vaccinations in the end-stage renal disease Medicare beneficiary population, an analysis of claims data 2006-2015.
Shen AK; Kelman JA; Warnock R; Zhang W; Brereton S; McKean S; Wernecke M; Chu S; Gellin BG
Vaccine; 2017 Dec; 35(52):7302-7308. PubMed ID: 29132990
[TBL] [Abstract][Full Text] [Related]
14. Effect of different synthetic membranes on laboratory parameters and survival in chronic haemodialysis patients.
Kreusser W; Reiermann S; Vogelbusch G; Bartual J; Schulze-Lohoff E
NDT Plus; 2010 May; 3(Suppl 1):i12-i19. PubMed ID: 27046088
[No Abstract] [Full Text] [Related]
15. Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients.
Schwabe RF; Engelmann H; Hess S; Fricke H
Clin Exp Immunol; 1999 Jul; 117(1):153-8. PubMed ID: 10403929
[TBL] [Abstract][Full Text] [Related]
16. A new polymethylmethacrylate membrane for hemodialysis.
Bonomini M; Fiederling B; Bucciarelli T; Manfrini V; Di Ilio C; Albertazzi A
Int J Artif Organs; 1996 Apr; 19(4):232-9. PubMed ID: 8786174
[TBL] [Abstract][Full Text] [Related]
17. The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels.
Galli F; Benedetti S; Buoncristiani U; Piroddi M; Conte C; Canestrari F; Buoncristiani E; Floridi A
Kidney Int; 2003 Aug; 64(2):748-55. PubMed ID: 12846775
[TBL] [Abstract][Full Text] [Related]
18. Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal disease population unresponsive to primary vaccination series.
Yousaf F; Gandham S; Galler M; Spinowitz B; Charytan C
Ren Fail; 2015 Aug; 37(7):1080-8. PubMed ID: 26258528
[TBL] [Abstract][Full Text] [Related]
19. Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels.
Tessitore N; Lapolla A; Aricò NC; Poli A; Gammaro L; Bassi A; Bedogna V; Corgnati A; Reitano R; Fedele D; Lupo A
J Nephrol; 2004; 17(5):707-14. PubMed ID: 15593039
[TBL] [Abstract][Full Text] [Related]
20. Serum soluble CD40 is associated with liver injury in patients with chronic hepatitis B.
Shen HH; Bai BK; Wang YQ; Zhou G; Hou J; Hu Y; Zhao JM; Li BS; Huang HL; Mao PY
Exp Ther Med; 2015 Mar; 9(3):999-1005. PubMed ID: 25667667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
